Physician profile
David Nelson Wright
NPI 1902857717
$5,818.50
in general payments reported to CMS, 2019-2025
44 companies · $397 in 2025
The $397 reported for 2025 was less than what a typical Allergy & Immunology (Internal Medicine) provider received nationally (typical 2025 total: $681).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,719 · 2020: $2,201 · 2021: $1,424 · 2024: $77.05 · 2025: $397.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $338 · Food and Beverage: $137.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $337.87 |
| Food and Beverage | $136.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $818.00 | 2019-2021 | |
| Biohaven Pharmaceuticals, INC. | $468.71 | 2020-2021 | |
| Allergan, INC. | $348.65 | 2019-2021 | |
| Glaxosmithkline, LLC. | $338.56 | 2019-2021 | |
| Stryker Corporation | $337.87 | 2025 | Inspace |
| Genzyme Corporation | $256.21 | 2019-2025 | |
| Csl Behring | $227.20 | 2019-2021 | |
| Optinose US, INC. | $223.71 | 2020-2021 | |
| Abbvie INC. | $220.32 | 2021 | |
| Eisai INC. | $217.86 | 2020-2021 | |
| Lilly USA, LLC | $209.72 | 2019-2021 | |
| Insmed, INC. | $207.68 | 2019-2020 | |
| Jazz Pharmaceuticals INC. | $175.91 | 2019 | |
| Amgen INC. | $169.75 | 2020-2021 | |
| Genentech USA, INC. | $155.05 | 2019-2021 |
Show all 44 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Wright listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.